Xin Zhang

This study identifies risk factors and immunological features associated with SARS-CoV-2 RNA re-positivity in recovered COVID-19 patients, finding CD8+ T-cell levels as an independent risk factor.

This study shows that sulindac enhances anti-PD-L1 immunotherapy efficacy in TNBC by reducing exosomal PD-L1 and increasing T cell infiltration.

This paper introduces a novel large-scale EV production strategy with upstream fed-batch suspension cell culture and downstream chromatographic purification for clinical applications.